A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(6 sites)

United States

Dignity Health Chandler Regional Medical Center, Chandler, Arizona

Memorial Health University Medical Center, Savannah, Georgia

University Health, Kansas City, Missouri

Bryan Medical Center, Lincoln, Nebraska

Novant Healthcare, Winston-Salem, North Carolina

Oregon Health & Science University (OHSU), Portland, Oregon